S&P BSE 250 SmallCap Index News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on S&P BSE 250 SmallCap Index from all sources in a single place.

IndiaMART InterMESH Ltd.

21 May 2025, 12:07PM

2384.30

0.88%

Company Update

IndiaMART InterMESH Ltd - 542726 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find attached herewith the publication of newspaper advertisement regarding the completion of dispatch of Notice of 26th Annual General Meeting of the Company including e-voting information and Integrated Annual Report for FY 2024-25 through electronic mode.

pdf

BLS International Services Ltd.

21 May 2025, 12:03PM

397.00

0.92%

Company Update

BLS International Services Ltd - 540073 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

In compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), we are hereby enclosing copies of Newspaper advertisement of Audited Financial Results of the Company for the fourth quarter and year ended on March 31, 2025, published today i.e. Friday, May 16, 2025.

pdf

BASF India Ltd.

21 May 2025, 11:59AM

5134.90

-3.19%

Company Update

BASF India Ltd - 500042 - Response To BSE Email Dated 21St May 2025 Regarding The …

BSE India

Response letter dated 21st May 2025 attached regarding the increase in volume observed in BASF India shares

pdf

AstraZeneca Pharma India Ltd.

21 May 2025, 11:58AM

7992.50

0.88%

Board Meeting

AstraZeneca Pharma India Ltd - 506820 - Board Meeting Intimation for Meeting Of The Board Of …

BSE India

Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. The audited financial results of the Company for the quarter and year ended March 31, 2025. 2. To recommend Dividend, if any, on the equity shares of the Company for the financial year 2024-25. We also inform you that the 'Trading Window' remains closed for all Designated Persons, from March 16, 2025 to June 1, 2025 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.

pdf